)

Dr. Reddy’s Laboratories (DRREDDY) investor relations material
Dr. Reddy’s Laboratories Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved 11% year-over-year revenue growth in Q1FY26, with broad-based performance and strong cash position, offset by softness and price erosion in the US generics segment.
Advanced key pipeline assets, expanded biosimilars through collaborations, and completed NRT business integration in Europe.
Underwent USFDA inspections at multiple sites, with Form 483 observations and a 'VAI' outcome for Middleburg.
Maintained leadership in ESG, being the only pharma company with a CDP Climate rating of 'A'.
Profit after tax attributable to equity holders was ₹14.2 billion, up 2% year-over-year.
Financial highlights
Consolidated revenue reached $997M/₹85.5B, up 11% year-over-year, flat sequentially; EBITDA margin at 26.7%.
Gross margin was 56.9%, down 350 bps YoY but up 134 bps sequentially; net income at $166M/₹14.2B, up 2% YoY.
SG&A expenses rose 13% YoY, mainly due to investments in consumer health and JV businesses.
R&D spend was $73M/₹6.2B, 7.3% of sales, flat YoY, down sequentially.
Free cash flow for the quarter was $51M/₹4.5B; net cash surplus at $341M/₹29.2B as of June 30, 2025.
Outlook and guidance
US generics expected to be flat to low single-digit growth, with recovery dependent on new launches and pricing pressure on Lenalidomide.
Semaglutide launch in Canada targeted for early 2026, with other markets following post-March.
Gross margins expected to remain at current levels for FY26; SG&A to be in the 28–30% range of sales.
R&D investments guided at 7–7.5% of sales for the full year.
Focus on strengthening core businesses, innovation, and operational efficiency.
Next Dr. Reddy’s Laboratories earnings date

Next Dr. Reddy’s Laboratories earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage